News & AnalysisStämm rakes in $17m Series AStämm, a biotechnology company, has raised $17 million in Series A funding.ByIris Dorbian17 March 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsBriefs